Company Filing History:
2 out of 2 
1 out of 1 Years Active: 1989-2008
Title: Hildebert Wagner: Innovator in Neurological Pharmaceutical Compositions
Introduction
Hildebert Wagner, an inventive mind based in Breitbrunn, Germany, has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for neurological diseases. With a total of three patents to his name, his work emphasizes innovation in therapeutic compositions using plant seeds.
Latest Patents
Hildebert Wagner's latest patents showcase groundbreaking advancements in pharmaceutical compositions. One patent describes the formulation of pharmaceutical compositions comprising seeds or seed components, aimed at preventing, alleviating, or treating neurological diseases. This invention highlights the potential for seed powder in neuroprotection and neurostimulation, as well as methods for preparing extracts for treating disorders such as Parkinson's Disease. This innovative approach aims to improve L-Dopa therapy's efficacy and safety.
Another patent focuses on the use of the plant Phyllanthus for treating chronic inflammatory and fibrotic processes. It details how Phyllanthus can prevent or treat connective tissue proliferations while maintaining levels of reduced glutathione and inhibiting nitric oxide synthase and cyclooxygenase-2 protein expression.
Career Highlights
Throughout his career, Hildebert Wagner has been associated with notable companies in the pharmaceutical industry, including Phytrix AG, Lomapharm, and Rudolf Lohmann GmbH. His dedication to research and innovation has established him as a respected figure in the development of pharmaceutical therapies.
Collaborations
Hildebert Wagner has collaborated with distinguished professionals such as Meinhart H. Zenk and Holger Ott. These partnerships have contributed to the advancement of research in the pharmaceutical field and have enhanced the efficacy of his inventions.
Conclusion
Hildebert Wagner's contributions to the pharmaceutical industry demonstrate his commitment to improving treatment options for neurological diseases. His patents reflect a significant forward step in the use of natural substances in medicine, showcasing his role as a pioneer in the field of pharmacological innovation.